Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2019
A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations
Sally L George, Elisa Izquierdo, James Campbell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2025
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC study
Fernando Carceller, Francisco Bautista, Harm Van Tinteren, et al.
Cancer Discovery
|
November 5, 2021
DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
Elisa Izquierdo, Diana M Carvalho, Alan Mackay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2025
The spectrum of IDH- and H3-wildtype high-grade glioma subgroups occurring across teenage and young adult patient populations
Rita Pereira, Alan Mackay, Yura Grabovska, et al.
Neuro-Oncology Advances
|
March 30, 2026
Characterization of patient-derived site-specific <i>in vivo</i> models of pediatric-type diffuse high-grade glioma using magnetic resonance imaging
Jessica K R Boult, Diana M Carvalho, Ketty Kessler, et al.
Cancer Discovery
|
October 12, 2023
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium
Anirban Das, Nicholas R Fernandez, Adrian Levine, et al.
Cancer Cell
|
September 4, 2024
GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant
Ilon Liu, Gustavo Alencastro Veiga Cruzeiro, Lynn Bjerke, et al.
Neuro-Oncology
|
June 28, 2023
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome
Anna S Kolodziejczak, Lea Guerrini-Rousseau, Julien Masliah Planchon, et al.
Cancer Discovery
|
April 3, 2020
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
Matthew Clarke, Alan Mackay, Britta Ismer, et al.
The Lancet. Oncology
|
March 29, 2024
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study
Ayse Bahar Ercan, Melyssa Aronson, Nicholas R Fernandez, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2019
A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations
Sally L George, Elisa Izquierdo, James Campbell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2025
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC study
Fernando Carceller, Francisco Bautista, Harm Van Tinteren, et al.
Cancer Discovery
|
November 5, 2021
DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
Elisa Izquierdo, Diana M Carvalho, Alan Mackay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2025
The spectrum of IDH- and H3-wildtype high-grade glioma subgroups occurring across teenage and young adult patient populations
Rita Pereira, Alan Mackay, Yura Grabovska, et al.
Neuro-Oncology Advances
|
March 30, 2026
Characterization of patient-derived site-specific <i>in vivo</i> models of pediatric-type diffuse high-grade glioma using magnetic resonance imaging
Jessica K R Boult, Diana M Carvalho, Ketty Kessler, et al.
Cancer Discovery
|
October 12, 2023
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium
Anirban Das, Nicholas R Fernandez, Adrian Levine, et al.
Cancer Cell
|
September 4, 2024
GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant
Ilon Liu, Gustavo Alencastro Veiga Cruzeiro, Lynn Bjerke, et al.
Neuro-Oncology
|
June 28, 2023
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome
Anna S Kolodziejczak, Lea Guerrini-Rousseau, Julien Masliah Planchon, et al.
Cancer Discovery
|
April 3, 2020
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
Matthew Clarke, Alan Mackay, Britta Ismer, et al.
The Lancet. Oncology
|
March 29, 2024
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study
Ayse Bahar Ercan, Melyssa Aronson, Nicholas R Fernandez, et al.
Page
of 8